nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—CYP3A4—type 2 diabetes mellitus	0.173	1	CbGaD
Levomilnacipran—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0358	0.064	CbGbCtD
Levomilnacipran—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0286	0.0512	CbGbCtD
Levomilnacipran—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0272	0.0486	CbGbCtD
Levomilnacipran—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0259	0.0463	CbGbCtD
Levomilnacipran—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0255	0.0457	CbGbCtD
Levomilnacipran—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0242	0.0433	CbGbCtD
Levomilnacipran—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0239	0.0427	CbGbCtD
Levomilnacipran—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0231	0.0413	CbGbCtD
Levomilnacipran—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0217	0.0388	CbGbCtD
Levomilnacipran—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0217	0.0388	CbGbCtD
Levomilnacipran—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.02	0.0358	CbGbCtD
Levomilnacipran—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0194	0.0346	CbGbCtD
Levomilnacipran—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0188	0.0336	CbGbCtD
Levomilnacipran—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0175	0.0313	CbGbCtD
Levomilnacipran—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0165	0.0295	CbGbCtD
Levomilnacipran—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0163	0.0291	CbGbCtD
Levomilnacipran—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0152	0.0272	CbGbCtD
Levomilnacipran—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0145	0.026	CbGbCtD
Levomilnacipran—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0133	0.0237	CbGbCtD
Levomilnacipran—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0125	0.0224	CbGbCtD
Levomilnacipran—CYP2C8—Losartan—type 2 diabetes mellitus	0.0121	0.0217	CbGbCtD
Levomilnacipran—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.012	0.0215	CbGbCtD
Levomilnacipran—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.012	0.0214	CbGbCtD
Levomilnacipran—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0116	0.0208	CbGbCtD
Levomilnacipran—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0111	0.0199	CbGbCtD
Levomilnacipran—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0105	0.0188	CbGbCtD
Levomilnacipran—CYP2C19—Losartan—type 2 diabetes mellitus	0.0102	0.0182	CbGbCtD
Levomilnacipran—ABCB1—Glyburide—type 2 diabetes mellitus	0.00897	0.016	CbGbCtD
Levomilnacipran—ABCB1—Losartan—type 2 diabetes mellitus	0.00821	0.0147	CbGbCtD
Levomilnacipran—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00796	0.0142	CbGbCtD
Levomilnacipran—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00763	0.0136	CbGbCtD
Levomilnacipran—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00763	0.0136	CbGbCtD
Levomilnacipran—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00721	0.0129	CbGbCtD
Levomilnacipran—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00538	0.00961	CbGbCtD
Levomilnacipran—CYP3A4—Losartan—type 2 diabetes mellitus	0.00492	0.00879	CbGbCtD
Levomilnacipran—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00286	0.219	CbGeAlD
Levomilnacipran—CYP2J2—artery—type 2 diabetes mellitus	0.0023	0.176	CbGeAlD
Levomilnacipran—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00192	0.147	CbGeAlD
Levomilnacipran—SLC6A2—nerve—type 2 diabetes mellitus	0.00108	0.0827	CbGeAlD
Levomilnacipran—CYP2J2—nephron tubule—type 2 diabetes mellitus	0.000889	0.0679	CbGeAlD
Levomilnacipran—CYP2J2—cardiovascular system—type 2 diabetes mellitus	0.000798	0.061	CbGeAlD
Levomilnacipran—CYP2J2—liver—type 2 diabetes mellitus	0.000494	0.0377	CbGeAlD
Levomilnacipran—CYP2C8—kidney—type 2 diabetes mellitus	0.000305	0.0233	CbGeAlD
Levomilnacipran—CYP2C19—liver—type 2 diabetes mellitus	0.000221	0.0169	CbGeAlD
Levomilnacipran—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000206	0.0158	CbGeAlD
Levomilnacipran—CYP3A4—kidney—type 2 diabetes mellitus	0.000206	0.0158	CbGeAlD
Levomilnacipran—CYP2D6—kidney—type 2 diabetes mellitus	0.000203	0.0155	CbGeAlD
Levomilnacipran—CYP2C8—liver—type 2 diabetes mellitus	0.000193	0.0147	CbGeAlD
Levomilnacipran—ABCB1—retina—type 2 diabetes mellitus	0.000176	0.0135	CbGeAlD
Levomilnacipran—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000166	0.0127	CbGeAlD
Levomilnacipran—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000149	0.0114	CbGeAlD
Levomilnacipran—ABCB1—kidney—type 2 diabetes mellitus	0.000146	0.0112	CbGeAlD
Levomilnacipran—ABCB1—pancreas—type 2 diabetes mellitus	0.000145	0.0111	CbGeAlD
Levomilnacipran—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000142	0.0109	CbGeAlD
Levomilnacipran—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000132	0.0101	CbGeAlD
Levomilnacipran—CYP3A4—liver—type 2 diabetes mellitus	0.00013	0.00997	CbGeAlD
Levomilnacipran—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000129	0.000716	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000128	0.000713	CcSEcCtD
Levomilnacipran—CYP2D6—liver—type 2 diabetes mellitus	0.000128	0.00981	CbGeAlD
Levomilnacipran—Anorexia—Valsartan—type 2 diabetes mellitus	0.000128	0.000712	CcSEcCtD
Levomilnacipran—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000128	0.00071	CcSEcCtD
Levomilnacipran—Chest pain—Metformin—type 2 diabetes mellitus	0.000128	0.000709	CcSEcCtD
Levomilnacipran—Headache—Pioglitazone—type 2 diabetes mellitus	0.000127	0.000706	CcSEcCtD
Levomilnacipran—Syncope—Irbesartan—type 2 diabetes mellitus	0.000127	0.000705	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000127	0.000705	CcSEcCtD
Levomilnacipran—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000127	0.000704	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000126	0.000702	CcSEcCtD
Levomilnacipran—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000126	0.000701	CcSEcCtD
Levomilnacipran—Nausea—Glipizide—type 2 diabetes mellitus	0.000126	0.000699	CcSEcCtD
Levomilnacipran—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000126	0.000698	CcSEcCtD
Levomilnacipran—Hypotension—Valsartan—type 2 diabetes mellitus	0.000126	0.000698	CcSEcCtD
Levomilnacipran—Vision blurred—Losartan—type 2 diabetes mellitus	0.000126	0.000697	CcSEcCtD
Levomilnacipran—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000125	0.000696	CcSEcCtD
Levomilnacipran—Constipation—Gliclazide—type 2 diabetes mellitus	0.000125	0.000695	CcSEcCtD
Levomilnacipran—Tremor—Losartan—type 2 diabetes mellitus	0.000125	0.000693	CcSEcCtD
Levomilnacipran—Rash—Glimepiride—type 2 diabetes mellitus	0.000125	0.000692	CcSEcCtD
Levomilnacipran—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000124	0.000691	CcSEcCtD
Levomilnacipran—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000124	0.000691	CcSEcCtD
Levomilnacipran—Rash—Sitagliptin—type 2 diabetes mellitus	0.000124	0.00069	CcSEcCtD
Levomilnacipran—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000124	0.000689	CcSEcCtD
Levomilnacipran—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000124	0.000689	CcSEcCtD
Levomilnacipran—Headache—Glimepiride—type 2 diabetes mellitus	0.000124	0.000688	CcSEcCtD
Levomilnacipran—Headache—Sitagliptin—type 2 diabetes mellitus	0.000123	0.000685	CcSEcCtD
Levomilnacipran—Agitation—Losartan—type 2 diabetes mellitus	0.000122	0.00068	CcSEcCtD
Levomilnacipran—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000122	0.000679	CcSEcCtD
Levomilnacipran—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000122	0.000678	CcSEcCtD
Levomilnacipran—Flushing—Ramipril—type 2 diabetes mellitus	0.000122	0.000677	CcSEcCtD
Levomilnacipran—Infection—Metformin—type 2 diabetes mellitus	0.000122	0.000676	CcSEcCtD
Levomilnacipran—Insomnia—Valsartan—type 2 diabetes mellitus	0.000122	0.000675	CcSEcCtD
Levomilnacipran—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000121	0.000671	CcSEcCtD
Levomilnacipran—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000121	0.00067	CcSEcCtD
Levomilnacipran—Shock—Metformin—type 2 diabetes mellitus	0.00012	0.000669	CcSEcCtD
Levomilnacipran—Insomnia—Orlistat—type 2 diabetes mellitus	0.00012	0.000667	CcSEcCtD
Levomilnacipran—Anxiety—Irbesartan—type 2 diabetes mellitus	0.00012	0.000667	CcSEcCtD
Levomilnacipran—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00012	0.000667	CcSEcCtD
Levomilnacipran—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00012	0.000667	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.00012	0.000666	CcSEcCtD
Levomilnacipran—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00012	0.000666	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00012	0.000665	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00012	0.000665	CcSEcCtD
Levomilnacipran—Somnolence—Valsartan—type 2 diabetes mellitus	0.00012	0.000664	CcSEcCtD
Levomilnacipran—Syncope—Losartan—type 2 diabetes mellitus	0.000119	0.000664	CcSEcCtD
Levomilnacipran—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000119	0.000663	CcSEcCtD
Levomilnacipran—Leukopenia—Losartan—type 2 diabetes mellitus	0.000119	0.000662	CcSEcCtD
Levomilnacipran—Skin disorder—Metformin—type 2 diabetes mellitus	0.000119	0.000661	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000118	0.000657	CcSEcCtD
Levomilnacipran—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000118	0.000657	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000118	0.000657	CcSEcCtD
Levomilnacipran—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000655	CcSEcCtD
Levomilnacipran—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000118	0.000655	CcSEcCtD
Levomilnacipran—Palpitations—Losartan—type 2 diabetes mellitus	0.000118	0.000654	CcSEcCtD
Levomilnacipran—Nausea—Glimepiride—type 2 diabetes mellitus	0.000117	0.000652	CcSEcCtD
Levomilnacipran—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000117	0.00065	CcSEcCtD
Levomilnacipran—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000117	0.00065	CcSEcCtD
Levomilnacipran—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000117	0.00065	CcSEcCtD
Levomilnacipran—Asthenia—Glyburide—type 2 diabetes mellitus	0.000117	0.000649	CcSEcCtD
Levomilnacipran—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000117	0.000649	CcSEcCtD
Levomilnacipran—Anorexia—Metformin—type 2 diabetes mellitus	0.000117	0.000648	CcSEcCtD
Levomilnacipran—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000116	0.000646	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000116	0.000645	CcSEcCtD
Levomilnacipran—Fatigue—Valsartan—type 2 diabetes mellitus	0.000116	0.000644	CcSEcCtD
Levomilnacipran—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000116	0.000643	CcSEcCtD
Levomilnacipran—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000116	0.000643	CcSEcCtD
Levomilnacipran—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000115	0.000642	CcSEcCtD
Levomilnacipran—Pruritus—Glyburide—type 2 diabetes mellitus	0.000115	0.00064	CcSEcCtD
Levomilnacipran—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000115	0.000639	CcSEcCtD
Levomilnacipran—Constipation—Valsartan—type 2 diabetes mellitus	0.000115	0.000639	CcSEcCtD
Levomilnacipran—Infection—Irbesartan—type 2 diabetes mellitus	0.000115	0.000638	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000115	0.000637	CcSEcCtD
Levomilnacipran—Fatigue—Orlistat—type 2 diabetes mellitus	0.000115	0.000636	CcSEcCtD
Levomilnacipran—Hypotension—Metformin—type 2 diabetes mellitus	0.000114	0.000635	CcSEcCtD
Levomilnacipran—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000114	0.000635	CcSEcCtD
Levomilnacipran—Shock—Irbesartan—type 2 diabetes mellitus	0.000114	0.000631	CcSEcCtD
Levomilnacipran—Chest pain—Losartan—type 2 diabetes mellitus	0.000113	0.00063	CcSEcCtD
Levomilnacipran—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000113	0.00063	CcSEcCtD
Levomilnacipran—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000113	0.000629	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000113	0.000628	CcSEcCtD
Levomilnacipran—Anxiety—Losartan—type 2 diabetes mellitus	0.000113	0.000628	CcSEcCtD
Levomilnacipran—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000113	0.000626	CcSEcCtD
Levomilnacipran—Rash—Bromocriptine—type 2 diabetes mellitus	0.000112	0.000624	CcSEcCtD
Levomilnacipran—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000112	0.000624	CcSEcCtD
Levomilnacipran—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000112	0.000623	CcSEcCtD
Levomilnacipran—Tension—Ramipril—type 2 diabetes mellitus	0.000112	0.000623	CcSEcCtD
Levomilnacipran—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000112	0.000621	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000112	0.00062	CcSEcCtD
Levomilnacipran—Headache—Bromocriptine—type 2 diabetes mellitus	0.000112	0.00062	CcSEcCtD
Levomilnacipran—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000112	0.000619	CcSEcCtD
Levomilnacipran—Dry mouth—Losartan—type 2 diabetes mellitus	0.000111	0.000616	CcSEcCtD
Levomilnacipran—Anorexia—Irbesartan—type 2 diabetes mellitus	0.00011	0.000612	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00011	0.000611	CcSEcCtD
Levomilnacipran—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00011	0.000611	CcSEcCtD
Levomilnacipran—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000109	0.000606	CcSEcCtD
Levomilnacipran—Somnolence—Metformin—type 2 diabetes mellitus	0.000109	0.000605	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000109	0.000603	CcSEcCtD
Levomilnacipran—Infection—Losartan—type 2 diabetes mellitus	0.000108	0.0006	CcSEcCtD
Levomilnacipran—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000108	0.0006	CcSEcCtD
Levomilnacipran—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000108	0.000599	CcSEcCtD
Levomilnacipran—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000108	0.000599	CcSEcCtD
Levomilnacipran—Tremor—Ramipril—type 2 diabetes mellitus	0.000107	0.000595	CcSEcCtD
Levomilnacipran—Shock—Losartan—type 2 diabetes mellitus	0.000107	0.000594	CcSEcCtD
Levomilnacipran—Urticaria—Valsartan—type 2 diabetes mellitus	0.000107	0.000593	CcSEcCtD
Levomilnacipran—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000107	0.000592	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000106	0.000591	CcSEcCtD
Levomilnacipran—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000106	0.000591	CcSEcCtD
Levomilnacipran—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000106	0.00059	CcSEcCtD
Levomilnacipran—Tachycardia—Losartan—type 2 diabetes mellitus	0.000106	0.000589	CcSEcCtD
Levomilnacipran—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000106	0.000588	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000106	0.000587	CcSEcCtD
Levomilnacipran—Fatigue—Metformin—type 2 diabetes mellitus	0.000106	0.000586	CcSEcCtD
Levomilnacipran—Urticaria—Orlistat—type 2 diabetes mellitus	0.000106	0.000586	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000105	0.000584	CcSEcCtD
Levomilnacipran—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000105	0.000583	CcSEcCtD
Levomilnacipran—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000105	0.000583	CcSEcCtD
Levomilnacipran—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000105	0.000583	CcSEcCtD
Levomilnacipran—Agitation—Ramipril—type 2 diabetes mellitus	0.000105	0.000583	CcSEcCtD
Levomilnacipran—Constipation—Metformin—type 2 diabetes mellitus	0.000105	0.000582	CcSEcCtD
Levomilnacipran—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000104	0.000576	CcSEcCtD
Levomilnacipran—Anorexia—Losartan—type 2 diabetes mellitus	0.000104	0.000576	CcSEcCtD
Levomilnacipran—Vomiting—Glyburide—type 2 diabetes mellitus	0.000104	0.000576	CcSEcCtD
Levomilnacipran—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000104	0.000575	CcSEcCtD
Levomilnacipran—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000103	0.000572	CcSEcCtD
Levomilnacipran—Rash—Glyburide—type 2 diabetes mellitus	0.000103	0.000571	CcSEcCtD
Levomilnacipran—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000103	0.000571	CcSEcCtD
Levomilnacipran—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000103	0.00057	CcSEcCtD
Levomilnacipran—Syncope—Ramipril—type 2 diabetes mellitus	0.000102	0.000569	CcSEcCtD
Levomilnacipran—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000102	0.000568	CcSEcCtD
Levomilnacipran—Headache—Glyburide—type 2 diabetes mellitus	0.000102	0.000567	CcSEcCtD
Levomilnacipran—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000102	0.000565	CcSEcCtD
Levomilnacipran—Hypotension—Losartan—type 2 diabetes mellitus	0.000102	0.000564	CcSEcCtD
Levomilnacipran—Palpitations—Ramipril—type 2 diabetes mellitus	0.000101	0.000561	CcSEcCtD
Levomilnacipran—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.0001	0.000558	CcSEcCtD
Levomilnacipran—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.0001	0.000558	CcSEcCtD
Levomilnacipran—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.0001	0.000556	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.0001	0.000556	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.98e-05	0.000554	CcSEcCtD
Levomilnacipran—Fatigue—Irbesartan—type 2 diabetes mellitus	9.96e-05	0.000553	CcSEcCtD
Levomilnacipran—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.91e-05	0.00055	CcSEcCtD
Levomilnacipran—Convulsion—Ramipril—type 2 diabetes mellitus	9.9e-05	0.00055	CcSEcCtD
Levomilnacipran—Constipation—Irbesartan—type 2 diabetes mellitus	9.88e-05	0.000549	CcSEcCtD
Levomilnacipran—Insomnia—Losartan—type 2 diabetes mellitus	9.84e-05	0.000546	CcSEcCtD
Levomilnacipran—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.79e-05	0.000544	CcSEcCtD
Levomilnacipran—Paraesthesia—Losartan—type 2 diabetes mellitus	9.76e-05	0.000542	CcSEcCtD
Levomilnacipran—Urticaria—Metformin—type 2 diabetes mellitus	9.73e-05	0.00054	CcSEcCtD
Levomilnacipran—Chest pain—Ramipril—type 2 diabetes mellitus	9.73e-05	0.00054	CcSEcCtD
Levomilnacipran—Dyspnoea—Losartan—type 2 diabetes mellitus	9.69e-05	0.000538	CcSEcCtD
Levomilnacipran—Anxiety—Ramipril—type 2 diabetes mellitus	9.69e-05	0.000538	CcSEcCtD
Levomilnacipran—Nausea—Glyburide—type 2 diabetes mellitus	9.68e-05	0.000538	CcSEcCtD
Levomilnacipran—Abdominal pain—Metformin—type 2 diabetes mellitus	9.68e-05	0.000538	CcSEcCtD
Levomilnacipran—Dizziness—Gliclazide—type 2 diabetes mellitus	9.68e-05	0.000538	CcSEcCtD
Levomilnacipran—Somnolence—Losartan—type 2 diabetes mellitus	9.67e-05	0.000537	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	9.66e-05	0.000537	CcSEcCtD
Levomilnacipran—Asthenia—Valsartan—type 2 diabetes mellitus	9.65e-05	0.000536	CcSEcCtD
Levomilnacipran—Dyspepsia—Losartan—type 2 diabetes mellitus	9.57e-05	0.000532	CcSEcCtD
Levomilnacipran—Asthenia—Orlistat—type 2 diabetes mellitus	9.53e-05	0.000529	CcSEcCtD
Levomilnacipran—Pruritus—Valsartan—type 2 diabetes mellitus	9.51e-05	0.000528	CcSEcCtD
Levomilnacipran—Dry mouth—Ramipril—type 2 diabetes mellitus	9.51e-05	0.000528	CcSEcCtD
Levomilnacipran—Decreased appetite—Losartan—type 2 diabetes mellitus	9.45e-05	0.000525	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.45e-05	0.000525	CcSEcCtD
Levomilnacipran—Pruritus—Orlistat—type 2 diabetes mellitus	9.4e-05	0.000522	CcSEcCtD
Levomilnacipran—Fatigue—Losartan—type 2 diabetes mellitus	9.38e-05	0.000521	CcSEcCtD
Levomilnacipran—Vomiting—Gliclazide—type 2 diabetes mellitus	9.3e-05	0.000517	CcSEcCtD
Levomilnacipran—Constipation—Losartan—type 2 diabetes mellitus	9.3e-05	0.000517	CcSEcCtD
Levomilnacipran—ABCB1—liver—type 2 diabetes mellitus	9.23e-05	0.00705	CbGeAlD
Levomilnacipran—Rash—Gliclazide—type 2 diabetes mellitus	9.23e-05	0.000513	CcSEcCtD
Levomilnacipran—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.22e-05	0.000512	CcSEcCtD
Levomilnacipran—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.2e-05	0.000511	CcSEcCtD
Levomilnacipran—Urticaria—Irbesartan—type 2 diabetes mellitus	9.18e-05	0.00051	CcSEcCtD
Levomilnacipran—Shock—Ramipril—type 2 diabetes mellitus	9.17e-05	0.00051	CcSEcCtD
Levomilnacipran—Headache—Gliclazide—type 2 diabetes mellitus	9.17e-05	0.000509	CcSEcCtD
Levomilnacipran—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.14e-05	0.000508	CcSEcCtD
Levomilnacipran—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.13e-05	0.000507	CcSEcCtD
Levomilnacipran—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.13e-05	0.000507	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.13e-05	0.000507	CcSEcCtD
Levomilnacipran—Tachycardia—Ramipril—type 2 diabetes mellitus	9.1e-05	0.000505	CcSEcCtD
Levomilnacipran—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.09e-05	0.000505	CcSEcCtD
Levomilnacipran—Skin disorder—Ramipril—type 2 diabetes mellitus	9.06e-05	0.000503	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000501	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.89e-05	0.000494	CcSEcCtD
Levomilnacipran—Dizziness—Valsartan—type 2 diabetes mellitus	8.89e-05	0.000494	CcSEcCtD
Levomilnacipran—Anorexia—Ramipril—type 2 diabetes mellitus	8.89e-05	0.000494	CcSEcCtD
Levomilnacipran—Dizziness—Orlistat—type 2 diabetes mellitus	8.79e-05	0.000488	CcSEcCtD
Levomilnacipran—Asthenia—Metformin—type 2 diabetes mellitus	8.78e-05	0.000488	CcSEcCtD
Levomilnacipran—Hypotension—Ramipril—type 2 diabetes mellitus	8.71e-05	0.000484	CcSEcCtD
Levomilnacipran—Nausea—Gliclazide—type 2 diabetes mellitus	8.69e-05	0.000483	CcSEcCtD
Levomilnacipran—Pruritus—Metformin—type 2 diabetes mellitus	8.66e-05	0.000481	CcSEcCtD
Levomilnacipran—Urticaria—Losartan—type 2 diabetes mellitus	8.64e-05	0.00048	CcSEcCtD
Levomilnacipran—Abdominal pain—Losartan—type 2 diabetes mellitus	8.6e-05	0.000477	CcSEcCtD
Levomilnacipran—Body temperature increased—Losartan—type 2 diabetes mellitus	8.6e-05	0.000477	CcSEcCtD
Levomilnacipran—Vomiting—Valsartan—type 2 diabetes mellitus	8.55e-05	0.000475	CcSEcCtD
Levomilnacipran—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.000473	CcSEcCtD
Levomilnacipran—Rash—Valsartan—type 2 diabetes mellitus	8.48e-05	0.000471	CcSEcCtD
Levomilnacipran—Dermatitis—Valsartan—type 2 diabetes mellitus	8.47e-05	0.00047	CcSEcCtD
Levomilnacipran—Vomiting—Orlistat—type 2 diabetes mellitus	8.45e-05	0.000469	CcSEcCtD
Levomilnacipran—Insomnia—Ramipril—type 2 diabetes mellitus	8.43e-05	0.000468	CcSEcCtD
Levomilnacipran—Headache—Valsartan—type 2 diabetes mellitus	8.42e-05	0.000468	CcSEcCtD
Levomilnacipran—Diarrhoea—Metformin—type 2 diabetes mellitus	8.38e-05	0.000465	CcSEcCtD
Levomilnacipran—Rash—Orlistat—type 2 diabetes mellitus	8.38e-05	0.000465	CcSEcCtD
Levomilnacipran—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.37e-05	0.000465	CcSEcCtD
Levomilnacipran—Dermatitis—Orlistat—type 2 diabetes mellitus	8.37e-05	0.000465	CcSEcCtD
Levomilnacipran—Headache—Orlistat—type 2 diabetes mellitus	8.32e-05	0.000462	CcSEcCtD
Levomilnacipran—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.31e-05	0.000462	CcSEcCtD
Levomilnacipran—Asthenia—Irbesartan—type 2 diabetes mellitus	8.29e-05	0.00046	CcSEcCtD
Levomilnacipran—Somnolence—Ramipril—type 2 diabetes mellitus	8.29e-05	0.00046	CcSEcCtD
Levomilnacipran—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.21e-05	0.000456	CcSEcCtD
Levomilnacipran—Pruritus—Irbesartan—type 2 diabetes mellitus	8.17e-05	0.000454	CcSEcCtD
Levomilnacipran—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.11e-05	0.00045	CcSEcCtD
Levomilnacipran—Dizziness—Metformin—type 2 diabetes mellitus	8.1e-05	0.00045	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.05e-05	0.000447	CcSEcCtD
Levomilnacipran—Fatigue—Ramipril—type 2 diabetes mellitus	8.04e-05	0.000447	CcSEcCtD
Levomilnacipran—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.01e-05	0.000445	CcSEcCtD
Levomilnacipran—Nausea—Valsartan—type 2 diabetes mellitus	7.99e-05	0.000444	CcSEcCtD
Levomilnacipran—Constipation—Ramipril—type 2 diabetes mellitus	7.97e-05	0.000443	CcSEcCtD
Levomilnacipran—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.91e-05	0.000439	CcSEcCtD
Levomilnacipran—Nausea—Orlistat—type 2 diabetes mellitus	7.89e-05	0.000438	CcSEcCtD
Levomilnacipran—Asthenia—Losartan—type 2 diabetes mellitus	7.8e-05	0.000433	CcSEcCtD
Levomilnacipran—Vomiting—Metformin—type 2 diabetes mellitus	7.78e-05	0.000432	CcSEcCtD
Levomilnacipran—Rash—Metformin—type 2 diabetes mellitus	7.72e-05	0.000429	CcSEcCtD
Levomilnacipran—Dermatitis—Metformin—type 2 diabetes mellitus	7.71e-05	0.000428	CcSEcCtD
Levomilnacipran—Pruritus—Losartan—type 2 diabetes mellitus	7.69e-05	0.000427	CcSEcCtD
Levomilnacipran—Headache—Metformin—type 2 diabetes mellitus	7.67e-05	0.000426	CcSEcCtD
Levomilnacipran—Dizziness—Irbesartan—type 2 diabetes mellitus	7.64e-05	0.000424	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.62e-05	0.000424	CcSEcCtD
Levomilnacipran—Diarrhoea—Losartan—type 2 diabetes mellitus	7.44e-05	0.000413	CcSEcCtD
Levomilnacipran—Urticaria—Ramipril—type 2 diabetes mellitus	7.41e-05	0.000411	CcSEcCtD
Levomilnacipran—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000409	CcSEcCtD
Levomilnacipran—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000409	CcSEcCtD
Levomilnacipran—Vomiting—Irbesartan—type 2 diabetes mellitus	7.35e-05	0.000408	CcSEcCtD
Levomilnacipran—Rash—Irbesartan—type 2 diabetes mellitus	7.29e-05	0.000405	CcSEcCtD
Levomilnacipran—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.000404	CcSEcCtD
Levomilnacipran—Nausea—Metformin—type 2 diabetes mellitus	7.27e-05	0.000404	CcSEcCtD
Levomilnacipran—Headache—Irbesartan—type 2 diabetes mellitus	7.24e-05	0.000402	CcSEcCtD
Levomilnacipran—Dizziness—Losartan—type 2 diabetes mellitus	7.19e-05	0.000399	CcSEcCtD
Levomilnacipran—Vomiting—Losartan—type 2 diabetes mellitus	6.91e-05	0.000384	CcSEcCtD
Levomilnacipran—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.87e-05	0.000382	CcSEcCtD
Levomilnacipran—Nausea—Irbesartan—type 2 diabetes mellitus	6.86e-05	0.000381	CcSEcCtD
Levomilnacipran—Rash—Losartan—type 2 diabetes mellitus	6.86e-05	0.000381	CcSEcCtD
Levomilnacipran—Dermatitis—Losartan—type 2 diabetes mellitus	6.85e-05	0.00038	CcSEcCtD
Levomilnacipran—Headache—Losartan—type 2 diabetes mellitus	6.81e-05	0.000378	CcSEcCtD
Levomilnacipran—Asthenia—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000372	CcSEcCtD
Levomilnacipran—Pruritus—Ramipril—type 2 diabetes mellitus	6.6e-05	0.000366	CcSEcCtD
Levomilnacipran—Nausea—Losartan—type 2 diabetes mellitus	6.46e-05	0.000359	CcSEcCtD
Levomilnacipran—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000354	CcSEcCtD
Levomilnacipran—Dizziness—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000342	CcSEcCtD
Levomilnacipran—Vomiting—Ramipril—type 2 diabetes mellitus	5.93e-05	0.000329	CcSEcCtD
Levomilnacipran—Rash—Ramipril—type 2 diabetes mellitus	5.88e-05	0.000327	CcSEcCtD
Levomilnacipran—Dermatitis—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000326	CcSEcCtD
Levomilnacipran—Headache—Ramipril—type 2 diabetes mellitus	5.84e-05	0.000324	CcSEcCtD
Levomilnacipran—Nausea—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000308	CcSEcCtD
Levomilnacipran—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	8.16e-06	0.000109	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	8.15e-06	0.000109	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	8.03e-06	0.000108	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	7.99e-06	0.000107	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	7.99e-06	0.000107	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	7.96e-06	0.000107	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.85e-06	0.000105	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	7.84e-06	0.000105	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	7.82e-06	0.000105	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	7.82e-06	0.000105	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	7.82e-06	0.000105	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	7.8e-06	0.000104	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	7.8e-06	0.000104	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.79e-06	0.000104	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	7.79e-06	0.000104	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	7.79e-06	0.000104	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	7.79e-06	0.000104	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.78e-06	0.000104	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.78e-06	0.000104	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.78e-06	0.000104	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	7.74e-06	0.000104	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	7.68e-06	0.000103	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	7.65e-06	0.000102	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	7.61e-06	0.000102	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	7.6e-06	0.000102	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	7.6e-06	0.000102	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	7.6e-06	0.000102	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	7.6e-06	0.000102	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	7.55e-06	0.000101	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	7.51e-06	0.000101	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.51e-06	0.000101	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	7.5e-06	0.0001	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.46e-06	9.99e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.46e-06	9.99e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	7.45e-06	9.98e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	7.42e-06	9.94e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	7.35e-06	9.84e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	7.35e-06	9.84e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	7.33e-06	9.82e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	7.21e-06	9.65e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	7.2e-06	9.64e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	7.18e-06	9.61e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	7.18e-06	9.61e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	7.16e-06	9.59e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	7.16e-06	9.59e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	7.16e-06	9.59e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	7.16e-06	9.59e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	7.12e-06	9.53e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	7.08e-06	9.48e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	7.08e-06	9.48e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	7.05e-06	9.45e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7e-06	9.38e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	6.99e-06	9.36e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	6.98e-06	9.36e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	6.98e-06	9.36e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	6.98e-06	9.36e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.93e-06	9.29e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.93e-06	9.29e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.93e-06	9.29e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	6.91e-06	9.26e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	6.9e-06	9.24e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.87e-06	9.2e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	6.85e-06	9.18e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	6.82e-06	9.13e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	6.82e-06	9.13e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	6.82e-06	9.13e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	6.79e-06	9.1e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	6.78e-06	9.09e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	6.78e-06	9.09e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.7e-06	8.98e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	6.69e-06	8.96e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	6.65e-06	8.91e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	6.63e-06	8.88e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.52e-06	8.73e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.5e-06	8.71e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	6.49e-06	8.69e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	6.42e-06	8.6e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	6.42e-06	8.6e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	6.42e-06	8.6e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	6.39e-06	8.56e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	6.32e-06	8.46e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	6.32e-06	8.46e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	6.3e-06	8.45e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	6.25e-06	8.37e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	6.23e-06	8.35e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	6.16e-06	8.26e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	6.16e-06	8.26e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	6.16e-06	8.25e-05	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—AKT1—type 2 diabetes mellitus	6.16e-06	8.25e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.13e-06	8.21e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	6.11e-06	8.19e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	6.1e-06	8.18e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	6.06e-06	8.11e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	6.06e-06	8.11e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	6.01e-06	8.05e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.91e-06	7.92e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	5.91e-06	7.92e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.89e-06	7.9e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.89e-06	7.9e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.89e-06	7.9e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.89e-06	7.9e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.87e-06	7.87e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	5.85e-06	7.83e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.85e-06	7.83e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	5.82e-06	7.8e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.81e-06	7.78e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.81e-06	7.78e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	5.74e-06	7.69e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.66e-06	7.59e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.65e-06	7.57e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	5.57e-06	7.47e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.57e-06	7.46e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.57e-06	7.46e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	5.42e-06	7.27e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	5.32e-06	7.13e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.25e-06	7.04e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	5.22e-06	6.99e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.22e-06	6.99e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	5.21e-06	6.98e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	5.19e-06	6.96e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	5.19e-06	6.96e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	5.13e-06	6.87e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	5.09e-06	6.82e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.09e-06	6.82e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	5.07e-06	6.79e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	5.06e-06	6.78e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	5e-06	6.7e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	4.99e-06	6.69e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	4.98e-06	6.67e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.9e-06	6.57e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	4.86e-06	6.51e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	4.84e-06	6.48e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.8e-06	6.44e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.8e-06	6.44e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.8e-06	6.43e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.8e-06	6.43e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	4.79e-06	6.42e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.78e-06	6.4e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	4.75e-06	6.37e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	4.72e-06	6.33e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.71e-06	6.32e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.71e-06	6.31e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	4.7e-06	6.3e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.68e-06	6.27e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.68e-06	6.27e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.68e-06	6.27e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.65e-06	6.23e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	4.65e-06	6.23e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	4.64e-06	6.21e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	4.64e-06	6.21e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.58e-06	6.13e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.57e-06	6.12e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	4.55e-06	6.1e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	4.54e-06	6.08e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	4.52e-06	6.06e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.52e-06	6.05e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	4.51e-06	6.05e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	4.48e-06	6e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	4.46e-06	5.98e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	4.46e-06	5.97e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.45e-06	5.96e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	4.41e-06	5.91e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	4.41e-06	5.9e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.37e-06	5.85e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.35e-06	5.83e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	4.28e-06	5.73e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	4.28e-06	5.73e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	4.26e-06	5.71e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.2e-06	5.63e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.2e-06	5.63e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.2e-06	5.63e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	4.2e-06	5.62e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	4.18e-06	5.59e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	4.15e-06	5.56e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.12e-06	5.52e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.1e-06	5.49e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	4.1e-06	5.49e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.09e-06	5.47e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	4.06e-06	5.45e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4e-06	5.36e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	4e-06	5.35e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.98e-06	5.34e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.97e-06	5.31e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.94e-06	5.27e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.93e-06	5.27e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.9e-06	5.23e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.89e-06	5.21e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	3.89e-06	5.21e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.86e-06	5.17e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.84e-06	5.15e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.84e-06	5.15e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	3.81e-06	5.11e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.8e-06	5.09e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.8e-06	5.09e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.74e-06	5.01e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.68e-06	4.92e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.66e-06	4.91e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.64e-06	4.88e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.64e-06	4.88e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.62e-06	4.85e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	3.49e-06	4.68e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	3.47e-06	4.65e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	3.4e-06	4.56e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.39e-06	4.54e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	3.34e-06	4.48e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	3.34e-06	4.48e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.32e-06	4.45e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.19e-06	4.27e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.14e-06	4.2e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.14e-06	4.2e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.13e-06	4.19e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.12e-06	4.18e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	3.12e-06	4.18e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.08e-06	4.13e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	3.06e-06	4.1e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	3.04e-06	4.08e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.99e-06	4.01e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.98e-06	4e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.98e-06	4e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.91e-06	3.9e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.91e-06	3.9e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.91e-06	3.9e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.87e-06	3.84e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.86e-06	3.83e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.8e-06	3.75e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.79e-06	3.73e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.74e-06	3.68e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.74e-06	3.68e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.73e-06	3.66e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.71e-06	3.64e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.68e-06	3.59e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.66e-06	3.57e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.57e-06	3.45e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.52e-06	3.38e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.51e-06	3.36e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.44e-06	3.27e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.4e-06	3.22e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.39e-06	3.21e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.37e-06	3.17e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.09e-06	2.79e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.05e-06	2.74e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.88e-06	2.51e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.79e-06	2.4e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.79e-06	2.4e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.64e-06	2.2e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.54e-06	2.06e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.37e-06	1.84e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.34e-06	1.79e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.26e-06	1.69e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	8.25e-07	1.1e-05	CbGpPWpGaD
